EUVIMEDEUVIMED entdecken
EditorialKommentar

Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1%

Jean Carruthers iD

Aesthetic Surgery Journal · 2023

DOI: 10.1093/asj/sjad076 ↗

Kurz gefasst

Editorial in der Zeitschrift Aesthetic Surgery Journal, 2023. Verfasst von Jean Carruthers. Hauptthemen laut MEDLINE: Blepharoptosis, Clostridium botulinum, Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BlepharoptosisClostridium botulinumBotulinum Toxins, Type ANeuromuscular AgentsHumansOxymetazoline

Substanzen

OxymetazolineBotulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

ORCID-Profile: Jean Carruthers

Zitieren

APA

Carruthers, J. (2023). Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1%. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjad076

Vancouver

Carruthers J. Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1%. Aesthetic Surgery Journal. 2023. doi:10.1093/asj/sjad076

BibTeX
@article{Carruthers2023,
  author = {Carruthers, Jean},
  title = {Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1%},
  journal = {Aesthetic Surgery Journal},
  year = {2023},
  doi = {10.1093/asj/sjad076}
}
Kostenlos starten →